Dihydroceramide is produced de novo via fumonisin-sensitive ceramide synthase.
Dihydroceramide then gives rise to ceramide via fenretinide-sensitive desaturase.
Fenretinide + Foscan-mediated PDT (PDT) enhances dihydroceramide accumulation.
Fenretinide + PDT enhances fumonisin-sensitive apoptotic cell death.
Fenretinide + PDT improves long-term tumor cures.